Biblioteca Humberto Rosselli Quijano
Resultado de la búsqueda
1 búsqueda de la palabra clave 'Metilfenidato, Depresión, Farmacoterapia, Mirtazapina, Paliativo, Cáncer'
Refinar búsqueda Générer le flux rss de la recherche
Lien permanent de la recherche
Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients / Chongguan Ng en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.4 (Abril)
[artículo]
Título : Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients : A four-week, randomized, double-blinded, placebo-controlled study Tipo de documento: texto impreso Autores: Chongguan Ng, Autor ; Marco P.M. Boks, Autor ; Kit Roes, Autor Fecha de publicación: 2021 Artículo en la página: pp. 491-498 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Metilfenidato, Depresión, Farmacoterapia, Mirtazapina, Paliativo, Cáncer Resumen: This is a 4 week, randomized, double-blind, placebo-controlled study to examine the effects of methylphenidate as add-on therapy to mirtazapine compared to placebo for treatment of depression in terminally ill cancer patients. Link: ./index.php?lvl=notice_display&id=26968
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 491-498[artículo] Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients : A four-week, randomized, double-blinded, placebo-controlled study [texto impreso] / Chongguan Ng, Autor ; Marco P.M. Boks, Autor ; Kit Roes, Autor . - 2021 . - pp. 491-498.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 491-498
Palabras clave: Metilfenidato, Depresión, Farmacoterapia, Mirtazapina, Paliativo, Cáncer Resumen: This is a 4 week, randomized, double-blind, placebo-controlled study to examine the effects of methylphenidate as add-on therapy to mirtazapine compared to placebo for treatment of depression in terminally ill cancer patients. Link: ./index.php?lvl=notice_display&id=26968